Literature DB >> 22284415

Tracking interferon in autoimmunity.

Virginia Pascual1, Jacques Banchereau.   

Abstract

Type I interferon is a family of antiviral cytokines linked to human autoimmune diseases. In this issue of Immunity, Gall et al. (2012) characterize, in a murine model of autoimmunity, the origin and progression of the type I interferon response leading to disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID： 22284415      PMCID： PMC3694564          DOI： 10.1016/j.immuni.2012.01.007

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  11 in total

1.  Type I interferonopathies: a novel set of inborn errors of immunity.

Authors:  Yanick J Crow
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

2.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

Authors:  Alevtina Gall; Piper Treuting; Keith B Elkon; Yueh-Ming Loo; Michael Gale; Glen N Barber; Daniel B Stetson
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 3.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus.

Authors:  Sulaiman M Al-Mayouf; Asma Sunker; Reem Abdwani; Safiya Al Abrawi; Fathiya Almurshedi; Nadia Alhashmi; Abdullah Al Sonbul; Wafaa Sewairi; Aliya Qari; Eiman Abdallah; Mohammed Al-Owain; Saleh Al Motywee; Hanan Al-Rayes; Mais Hashem; Hanif Khalak; Latifa Al-Jebali; Fowzan S Alkuraya
Journal:  Nat Genet       Date:  2011-10-23       Impact factor: 38.330

5.  Mutation of DNASE1 in people with systemic lupus erythematosus.

Authors:  K Yasutomo; T Horiuchi; S Kagami; H Tsukamoto; C Hashimura; M Urushihara; Y Kuroda
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

Review 6.  Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.

Authors:  Kathryn H Richards; Andrew Macdonald
Journal:  Microbes Infect       Date:  2011-01-20       Impact factor: 2.700

7.  The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Musheng Bao; Ning Lu; Taeil Kim; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

8.  Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.

Authors:  Masashi Morita; Gordon Stamp; Peter Robins; Anna Dulic; Ian Rosewell; Geza Hrivnak; Graham Daly; Tomas Lindahl; Deborah E Barnes
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

Review 10.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

Authors:  Michel Gilliet; Wei Cao; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106
View more
  2 in total

1.  Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.

Authors:  Özlem Aydinoglu-Candan; Bilge Araz-Erşan; Ahmet Gul; Selim Badur; Ilknur Tugal-Tutkun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-12       Impact factor: 3.117

2.  PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.

Authors:  Yong Zhang; Dailing Mao; William T Roswit; Xiaohua Jin; Anand C Patel; Dhara A Patel; Eugene Agapov; Zhepeng Wang; Rose M Tidwell; Jeffrey J Atkinson; Guangming Huang; Ronald McCarthy; Jinsheng Yu; Nadezhda E Yun; Slobodan Paessler; T Glen Lawson; Natalie S Omattage; Tom J Brett; Michael J Holtzman
Journal:  Nat Immunol       Date:  2015-10-19       Impact factor: 25.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.